Replica Analytics
Stage
Acquired | AcquiredTotal Raised
$1MAbout Replica Analytics
Replica Analytics is a developer of technologies for generating privacy-protective, synthetic data that maintains the statistical properties of real data. The Replica Synthesis software provides a full suite of synthetic data generation and evaluation capabilities that can solve multiple grand challenges facing the life sciences industry and health research in general. On January 4th, 2022, Replica Analytics was acquired by Aetion. The terms of the transaction were not disclosed.
Missing: Replica Analytics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Replica Analytics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Replica Analytics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Replica Analytics in 1 CB Insights research brief, most recently on May 9, 2023.
May 9, 2023
7 applications of generative AI in healthcareExpert Collections containing Replica Analytics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Replica Analytics is included in 5 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
10,627 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Digital Health
10,348 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Cybersecurity
221 items
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Replica Analytics Patents
Replica Analytics has filed 4 patents.
The 3 most popular patent topics include:
- Data management
- Analysis of variance
- Bioinformatics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/19/2021 | Designer drugs, Cannabinoids, Privacy, Data management, Information privacy | Application |
Application Date | 4/19/2021 |
|---|---|
Grant Date | |
Title | |
Related Topics | Designer drugs, Cannabinoids, Privacy, Data management, Information privacy |
Status | Application |
Latest Replica Analytics News
May 26, 2023
Share Private AI, a leading provider of data privacy software solutions, and Replica Analytics Ltd., an Aetion company, the leading Synthetic Data Generation technology provider for the healthcare industry, are pleased to announce a new partnership. The need for a privacy-preserving solution in healthcare is urgent and this strategic partnership aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica Synthesis 3.0, Replica Analytics ‘ pioneering software generates synthetic structured data, in the place of real data, making healthcare data safe to use in medical research and for other valuable insights. Private AI’s industry-leading technology accurately detects and removes personally identifiable information from structured, semi-structured, and unstructured data – all of which are prevalent in the healthcare industry. “By joining Private AI’s unique technology with Replica Analytics’ solution, we are now able to tackle the challenge of unstructured text and offer a more comprehensive solution to our global clients,” said Dr. Khaled El Emam, Replica Analytics’ SVP and GM, who has been developing and deploying privacy enhancing technologies for two decades. “Our companies share a deep commitment to privacy and to using data for good. Working together, we will make richer datasets available, which is essential for health research and analytics, while continuing to protect privacy.” Related Posts “We are thrilled to partner with Replica Analytics and expand our cutting-edge data privacy solutions further into the healthcare industry through Replica Analytics and, in turn, expose their synthetic structured data generation product to other verticals,” said Patricia Thaine, CEO, and Co-Founder of Private AI. “With Replica Analytics’ synthetic data generation solutions, we can help our clients to create safe and secure data sets for tasks in which maintaining accurate statistical distributions of personally identifiable information are key.” This partnership will enable healthcare organizations to extract valuable insights from their multi-modal data while ensuring compliance with HIPAA regulations and maintaining the highest levels of privacy and data security. The two companies aim to make healthcare data available for research and development while preserving individual privacy rights.
Replica Analytics Frequently Asked Questions (FAQ)
Where is Replica Analytics's headquarters?
Replica Analytics's headquarters is located at 150 Elgin Street, Floor 10, Ottawa.
What is Replica Analytics's latest funding round?
Replica Analytics's latest funding round is Acquired.
How much did Replica Analytics raise?
Replica Analytics raised a total of $1M.
Who are the investors of Replica Analytics?
Investors of Replica Analytics include Aetion, Mitacs and Fight Against Cancer Innovation Trust.
Who are Replica Analytics's competitors?
Competitors of Replica Analytics include Syntegra and 1 more.
Compare Replica Analytics to Competitors
Unlearn builds machine-learning platforms to create biological digital twins for the healthcare and pharmaceutical industries. It develops generative machine learning methods to predict individual health outcomes and accelerate clinical innovation. It works with biopharma companies and regulators to ensure its methods meet scientific and regulatory standards. It was founded in 2017 and is based in San Fransisco, California.
MDClone develops a system for ensuring patient confidentiality during the analysis of medical data. MDClone's system generates datasets combining real and fictitious patients, allowing researchers to conduct tests without exposing sensitive medical data and compromising personal details.
MOSTLY AI develops and offers a synthetic data engine. It provides realistic and representative synthetic data, analyzes and provides insights related to consumer behavior, and builds predictive models by using deep learning, machine learning, and artificial intelligence technologies. The company serves the banking, insurance, and telecommunications industries. It was founded in 2017 and is based in Vienna, Austria.
Syntegra employs machine learning models to enable low-burden access to privacy-preserved healthcare data. The result is AI-enabled synthetic data with the potential to accelerate the development of treatments for patients and improve patient care by making data easily shareable without compromising patient privacy. The company's synthetic data is built from the statistical patterns of data across healthcare modalities, serving a range of stakeholders, including large health systems, life sciences companies, payers, data scientists, and clinical research organizations.
Syntegra Healthcare Management Services is a Bethesda, Maryland-based Healthcare company.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.